May 14, 2012 – A retrospective analysis of data from the OMNI Registry, a large-scale, longitudinal registry of nearly 3,000 device patients, revealed that primary prevention non-evidence-based (NEB) implantable cardioverter-defibrillator (ICD) recipients had similar therapeutic benefits and outcomes as evidence-based (EB) ICD recipients.
